AMRI
Abstract: Given the known requirement of cytoskeletal dynamics in tumor metastasis, cytoskeletal components have proven to be viable targets of metastatic cancer therapies. Indeed, numerous small molecules and naturally derived products have proven effective in limiting tumor cell proliferation. Despite the success of bringing cytoskeletal dynamic disturbing agents to the cancer therapy market, numerous challenges remain.
Description:
Category: Discovery
Type: Small Molecules
Contact: Matthew Betzenhauser ([email protected])